Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation.
about
Plasmatic level of neurosin predicts outcome of mild cognitive impairment.Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14The emerging roles of human tissue kallikreins in cancerKallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft modelNatural and synthetic inhibitors of kallikrein-related peptidases (KLKs).Enzymatic properties of human kallikrein-related peptidase 12 (KLK12).A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.The kallikrein world: an update on the human tissue kallikreins.Recombinant kallikrein expression: site-specific integration for hK6 production in human cells.Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6.The autolytic regulation of human kallikrein-related peptidase 6.New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.Methodology and applications of disease biomarker identification in human serum.Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis.Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Putative functions of tissue kallikrein-related peptidases in vaginal fluid.Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors.Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer.Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer.Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects.Activation profiles and regulatory cascades of the human kallikrein-related peptidases.A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineeringImpact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer
P2860
Q21202048-DB414E79-B3F3-4C8D-8E86-1AADABBD2B31Q24316359-0EB7318F-78FB-4B87-96DA-A0A192B4A7B6Q28290701-0901C9FA-828B-445A-844C-6AABA41625C8Q28742738-9DD4238D-F7F2-4CEB-8E06-22B20B9146C8Q34457491-602D3BE4-AF05-440D-A0B9-DE9BF523D307Q34613040-A16B7B86-CFCB-4828-968D-E89077258A65Q36086721-C22A4F96-6113-44D4-8899-B1E1CC4ECD50Q36519354-586572E9-6733-4737-B7F6-1670791737EFQ36519374-00A4779D-0EAD-4641-9DC4-CA9E850C2432Q36560848-06CE3745-CEAB-4743-B663-2AFC28B4684CQ36840687-D3CE2AE9-1A6B-4E01-9CDC-71153EE7D6A8Q37453804-6AC80FC5-D5CC-4E0E-8795-6AC2CD01312EQ37574961-92D5AF4D-0F2C-4551-A9E0-58119CA659CDQ37686524-EEFA5DB5-E834-4446-9E12-9B134F9E0DC0Q37697808-DB7E4DC4-0AD5-43BD-A890-DB2A1E78CF50Q37716380-9E596359-E779-49F2-9905-5E5D3820956EQ37952006-0EB33975-41DC-464D-91F7-6569F11C5B44Q38948393-20063E5C-C4E1-45B1-B72B-57195A4BD545Q39369084-7CA57149-86D0-4F2B-BBDA-342564DF12D9Q39388749-B4781CB5-615C-4A6E-8BB3-C036F6B3FA4CQ39527940-2F606C12-A544-47CC-BBE1-C7F55A3C9FABQ39735807-0F9D4870-BDF4-4990-90F5-4922BC35436CQ39839292-D9C67DD0-2A8C-41F3-9CB7-BE274375639AQ40262739-80858454-B73F-4841-B916-6668A702E497Q40262755-D646E4D8-E369-4343-A841-107DEC5B2142Q46830854-82EA688D-FDAD-4580-96C1-68428763634DQ54434829-23619E22-39D4-4528-8E5E-76EA68736516Q56888917-0B28148B-FE33-4150-854B-5DDF32DB98E1Q57940964-F87CCB13-D45A-4601-A713-47928A40D3AE
P2860
Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Human kallikrein 6 activity is ...... sm of activation/inactivation.
@en
Human kallikrein 6 activity is ...... sm of activation/inactivation.
@nl
type
label
Human kallikrein 6 activity is ...... sm of activation/inactivation.
@en
Human kallikrein 6 activity is ...... sm of activation/inactivation.
@nl
prefLabel
Human kallikrein 6 activity is ...... sm of activation/inactivation.
@en
Human kallikrein 6 activity is ...... sm of activation/inactivation.
@nl
P2093
P2860
P50
P356
P1433
P1476
Human kallikrein 6 activity is ...... ism of activation/inactivation
@en
P2093
Georgia Sotiropoulou
Josep Vendrell
Theodoros Tsetsenis
P2860
P304
P356
10.1515/BC.2004.061
P577
2004-06-01T00:00:00Z